The UK Elastomeric Infusion Pumps Market was valued at $35.4 Million in 2025 and projected to reach to $44.8 Million by 2030, representing a compound annual growth rate of 4.8%. The UK elastomeric infusion pumps market is positioned for sustained growth through 2030, supported by increasing healthcare expenditure, NHS initiatives promoting home-based care, and growing patient demand for convenient, portable infusion solutions.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
The UK elastomeric infusion pumps market is valued at $35.4 million in 2025, with steady growth driven by healthcare modernization and increased adoption of advanced drug delivery technologies across the National Health Service and private healthcare providers.
The UK market is projected to reach $44.8 million by 2030, representing a CAGR of 4.8%, outpacing broader economic growth and reflecting strong demand for portable, patient-friendly infusion solutions in both hospital and home care environments.
The UK's advanced healthcare infrastructure, coupled with NHS investment in innovative medical devices and home-based care programs, creates a favorable environment for elastomeric infusion pump adoption and market expansion.
Rising preference for portable drug delivery systems and patient-centric infusion solutions is driving market growth across UK hospitals, clinics, and home care settings, particularly for chronic disease management and oncology treatments.
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | HOME CARE SETTINGS (Setting) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 5.3% from 2025 to 2030 |
| Largest Segment | ACCESSORIES AND CONSUMABLES (Product) |
| Market Size Base Year (Billions) | ~USD 1.15 (2025) |
| Revenue Forecast (Billions) | ~USD 1.49 (2030) |
| Segments Covered | Type, Application, End-Use Industry, Product, Setting |
5 segment dimensions are covered across the global market.
| Segment | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| AMBULATORY SURGICAL CENTERS (ASCS) | 8.45 | 8.78 | 9.21 | 9.66 | 10.14 | 10.63 | 11.15 | 11.7 | 4.9 |
| HOMECARE SETTINGS | 7.67 | 8.01 | 8.44 | 8.89 | 9.37 | 9.88 | 10.41 | 10.97 | 5.4 |
| HOSPITALS | 14.85 | 15.37 | 16.06 | 16.78 | 17.54 | 18.32 | 19.15 | 20.01 | 4.5 |
| OTHER END-USE INDUSTRIES | 1.57 | 1.62 | 1.69 | 1.76 | 1.83 | 1.91 | 1.99 | 2.07 | 4.2 |
| TOTAL | 32.54 | 33.78 | 35.4 | 37.1 | 38.88 | 40.75 | 42.7 | 44.75 | 4.8 |
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| BAXTER | United States | Public Company | Continuous Rate Elastomeric Pumps,Variable Rate Elastomeric Pumps,Chemotherapy Applications, |
| NIPRO | Japan | Public Company | Continuous Rate Elastomeric Pumps,Variable Rate Elastomeric Pumps,Chemotherapy Applications, |
| AVNS | United States | Private Company | Continuous Rate Elastomeric Pumps,Variable Rate Elastomeric Pumps,Chemotherapy Applications, |
| WOOYOUNG MEDICAL CO., LTD. | South Korea | Private Company | Continuous Rate Elastomeric Pumps,Variable Rate Elastomeric Pumps,Electronic Infusion Pumps (adjacent), |
| SHANGHAI INT MEDICAL INSTRUMENTS CO., LTD. | China | Public Company | Continuous Rate Elastomeric Pumps,Variable Rate Elastomeric Pumps,Accessories & Disposables for Elastomeric Pumps, |
| AMBU A/S | Denmark | Public Company | Continuous Rate Elastomeric Pumps,Variable Rate Elastomeric Pumps,Chemotherapy Applications, |
| DAIKEN MEDICAL CO., LTD. | Japan | Public Company | Continuous Rate Elastomeric Pumps,Variable Rate / PCA Elastomeric Pumps,Chemotherapy Applications, |
Baxter is a publicly traded American healthcare company founded in 1931 that employs 37,500 people. The company operates in the medical devices and pharmaceuticals sector.
Nipro is a Japanese public company founded in 1947 with 38,593 employees operating in the medical devices sector. The company serves global healthcare markets.
AVNS is a privately held American company founded in 2014 with 2,287 employees. The company operates in the medical devices industry.
Wooyoung Medical Co., Ltd. is a privately held South Korean company founded in 1996. The company operates in the medical devices sector.
Shanghai Int Medical Instruments Co., Ltd. is a publicly traded Chinese medical device company founded in 2006 with 2,088 employees. The company serves the healthcare market.
Ambu A/S is a publicly traded Danish medical device company founded in 1937 with 5,200 employees. The company specializes in emergency and surgical equipment.
Daiken Medical Co., Ltd. is a publicly traded Japanese medical device company founded in 1968 with 185 employees. The company serves the healthcare industry.
The UK elastomeric infusion pumps market is estimated at $35.4 million in 2025.
The UK elastomeric infusion pumps market is forecast to reach $44.8 million by 2030.
The UK market is expected to grow at a compound annual growth rate (CAGR) of 4.8% from 2025 to 2030.
Key drivers include an aging population, NHS initiatives promoting outpatient care, technological innovations in pump design, and increased adoption of portable drug delivery systems in the UK.
The UK elastomeric infusion pumps market is a significant segment within Europe, characterized by strong regulatory standards, advanced healthcare infrastructure, and competitive device manufacturers.
The study involved four major activities to estimate the current size of the global elastomeric infusion pumps market. Exhaustive secondary research was conducted to gather information on the market, the peer product market, and the parent product group market. The next step was to validate these findings, assumptions, and sizes with the industry experts across the value chain of elastomeric infusion pumps through primary research. The top-down and bottom-up approaches were employed to estimate the overall size of the elastomeric infusion pumps market. After that, market breakdown and data triangulation procedures were used to determine the size of different segments and sub-segments of the market.
The market for companies offering elastomeric infusion pumps is determined by secondary data obtained from paid and unpaid sources, analyzing the product portfolios of major companies in the ecosystem, and evaluating companies based on their performance and quality. Various secondary sources, including Business Standard, Bloomberg, the World Bank, and Factiva, were consulted to identify and collect information for this study on the elastomeric infusion pumps market. During the secondary research process, various secondary sources were consulted to identify and collect information relevant to the study. Secondary sources included annual reports, press releases, investor presentations of door vendors, forums, certified publications, and white papers. The secondary research was utilized to gather critical information on the industry’s value chain, the total pool of key players, market classification, and segmentation from both market- and technology-oriented perspectives.
In the primary research process, various primary sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side included industry experts, such as Chief Executive Officers (CEOs), Vice Presidents (VPs), marketing directors, technology and innovation directors, and related key executives from several key companies and organizations operating in the elastomeric infusion pump market. After completing the market engineering process (calculations for market statistics, market breakdown, market size estimations, market forecasting, and data triangulation), extensive primary research was conducted to gather information and verify and validate the critical numbers derived. Primary research was also conducted to identify the segmentation types, industry trends, competitive landscape of elastomeric infusion pumps offered by various market players, and key market dynamics, such as drivers, restraints, opportunities, challenges, industry trends, and key player strategies. In the complete market engineering process, the top-down and bottom-up approaches and several data triangulation methods were extensively used to perform the market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was performed on the complete market engineering process to list the key information/insights throughout the report.
The following is the breakdown of primary respondents:
Notes: Other designations include sales, marketing, and product managers. Tier 1: >USD 1 Billion; Tier 2: USD 500 million–1 Billion; and Tier 3: < USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
The top-down and bottom-up approaches were employed to estimate and validate the size of the global elastomeric infusion pumps market. These methods were also widely used to assess the size of various related market segments. The research methodology used to determine the market size included the following:

After determining the overall market size using market size estimation processes, the market was segmented into several segments and subsegments. The data triangulation and market breakup procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Elastomeric infusion pumps are portable, non-electronic medical devices designed for the controlled delivery of drugs, such as analgesics, antibiotics, and chemotherapeutic agents, over a specified period. These devices utilize the elastic properties of specific elastomers to deliver accurate, continuous, or intermittent medication infusions without requiring batteries or external power sources. Elastomeric infusion pumps are recognized for their simplicity, reliability, and ease of use, making them suitable for use in hospital, outpatient, and home care environments. They are produced and tested in accordance with international medical device standards, including ISO 13485 for quality management, ISO 11608 for infusion device efficacy, and ASTM standards for elastomeric materials. The devices are extensively utilized in oncology, pain management, anesthesia, and palliative care, enhancing patient compliance, mobility, and safety. Elastomeric infusion pumps are crucial to the advancement of the field of patient-centered drug delivery and healthcare innovation, particularly in home healthcare and ambulatory care.
Full forecast, segment splits, and company analysis for all Elastomeric Infusion Pumps Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report